Expert U.S. panel developed NIH treatment guidelines for COVID-19
On Apr. 21, 2020, a panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
On Apr. 21, 2020, a panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…
On Apr. 21, 2020, a study posted on medRxiv found no evidence that use of hydroxychloroquine, either with…
On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…
On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
On Apr. 16, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
On Apr. 13, 2020, a province wide trial was announced by Alberta Hope that will investigate the effectiveness…
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
On Apr. 9, 2020, Laurent Pharmaceuticals announced that a spin off from McGill University planned to test its…
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
On Apr. 9, 2020, CytoDyn announced results of immunological metrics from blood samples of seven severely ill COVID-19…
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
On Apr. 7, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
On Apr. 6, 2020, OraSure Technologies announced it had been awarded a $710,310 contract from the Biomedical Advanced…
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…